http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106178162-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3692 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36 |
filingDate | 2016-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106178162-B |
titleOfInvention | Treating AIDS organelle |
abstract | The present invention relates to the treating AIDS organelles of field of biomedicine, it is characterized in that isolating CD14 cell with immunomagnetic beads method, and then it prepares and had not only retained former macrophage feature but also the hybridoma macrophage strain of energy indeterminate growth, it selects to make amplification cultivation and preservation to the strong phagocytic clone of HIV, thus the hybridoma macrophage strain prepared prepared with high-biocompatibility material package can prevent cell and its fragment even HIV from filtering out, HIV capable of being swallowed for cell strain, the organelle in place is provided, extracorporal circulatory system is constituted with plasma separator, isolated blood plasma is after organelle filters out, HIV therein is swallowed by macrophage strain to be removed, the anti-infective macrophage cytokines generated simultaneously feed back internal with blood plasma, the AIDS hybridoma technology of macrophage cytokines needed for not only having removed HIV to realization but also supplemented is external New treatment, than being confined to kill HIV in vivo but the traditional remedies that are difficult to realize are more feasible and have no toxic side effect. |
priorityDate | 2016-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 182.